TwoKnct Media & Publishing

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics

Next-Wave Obesity Therapeutics & Drug Development Summit Europe

Turning breakthrough research into accessible, effective therapies.

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics

Welcome to The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026 unites global R&D leaders, biotech innovators, clinicians, and investors driving the next era of obesity and metabolic disease treatment.

From peptide and RNA therapeutics to small molecules and multi-agonist strategies, this summit bridges cutting-edge science and commercial execution — turning breakthrough research into accessible, effective therapies.

Eric HALIOUA

President & Chief Executive Officer PDC*line Pharma

Christopher P. Locher

CEO and co-founder Versatope Therapeutics

Kinkini Roy

Associate Director, Formulation Development AVICEDA THERAPEUTICS INC

Ilya Vensky

General Partner Provisio Ventures

Lélia Delamarre

Distinguished Scientist in Oncology Discovery Genentech.

Sean Bedingfield

Senior Advisor Eli Lilly & Co

View The Full Programme

Who Should Attend

  • Obesity & Metabolic Disease Researchers 
  • Pharma & Biotech R&D Executives 
  • Drug Development, Clinical & Regulatory Leaders 
  • Market Access & Commercial Strategy Professionals 
  • Endocrinologists, Clinician-Scientists & KOLs 
  • Investors & Business Development Leaders

Industries Represented

  • Biopharmaceutical & Biotech Companies 
  • Peptide, RNA & Metabolic Therapeutic Developers 
  • CROs & CDMOs 
  • Clinical Trial Design & Data Analytics Firms 
  • Market Access & Health Economics Consultancies 
  • Regulatory Agencies & Policy Experts

Key Themes

Next-Generation Targets in Obesity Therapeutics

  • Dual, triple, and multi-agonist strategies (GLP-1, GIP, glucagon, amylin) 
  • Central nervous system and appetite-regulation pathways 
  • RNA, gene-based, and peptide innovation for metabolic modulation

Clinical Development & Translational Science

  • Translating mechanism-based research into clinical success
  • Biomarker-driven patient stratification and endpoint design 
  • Long-term safety, tolerability, and efficacy management

Manufacturing & Drug Delivery Innovation

  • Scaling oral, injectable, and implantable formulations 
  • Overcoming cold-chain and stability challenges 
  • Partnerships with CDMOs for rapid, compliant production

Regulatory Strategy & Market Access

  •  EMA, FDA, and MHRA guidance for obesity indications 
  • Leveraging expedited pathways for metabolic diseases 
  • Evidence generation to meet HTA and payer expectations

Commercialisation & Strategic Partnerships

  • Pricing, licensing, and alliance models in obesity therapeutics 
  • Go-to-market planning for high-growth metabolic portfolios 
  • Pharma–biotech collaborations for co-development and launch

Digital Health, Real-World Data & Long-Term Outcomes

  •  Integrating wearables and ePROs in obesity trials 
  • Using AI and RWE to strengthen post-approval value demonstration 
  • Building sustainable, data-driven obesity care ecosystems

Upcoming Events

Next-Wave Obesity Therapeutics & Drug…

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics Next-Wave Obesity Therapeutics & Drug Development Summit Europe Turning breakthrough...

Read More

Multi-Omics Drug Discovery & Development…

Transforming Drug Development with Deep Multi-Omics Insights Multi-Omics Drug Discovery & Development Conference From Data Layers to Therapeutic Breakthroughs Speak,...

Read More

Advanced Therapy Medicinal Products Conference

Shaping the Future of Regenerative Medicine and Advanced Therapeutics Advanced Therapy Medicinal Products Conference Engineering the Future of Medicine —...

Read More

AI Law & Ethics Summit…

From Regulation to Responsibility: Building Trust in the Age of AI AI Law & Ethics Summit Europe 2026 Shaping a...

Read More

Targeted Protein Degradation Barcelona Summit…

Join global leaders in TPD, degrader development, and E3 ligase biology for two days of insight, innovation, and partnering. Targeted...

Read More

Reinsurance Barcelona Summit 2026

Reinsurance Barcelona Summit 2026 Welcome to the Reinsurance Barcelona Summit 2026 The Reinsurance Barcelona Summit is a premier international gathering of...

Read More

Next-Wave Obesity Therapeutics & Drug…

From Discovery to Delivery: Transforming Obesity Care Through Next-Generation Therapeutics Next-Wave Obesity Therapeutics & Drug Development Summit Europe Turning breakthrough...

Read More

Multi-Omics Drug Discovery & Development…

Transforming Drug Development with Deep Multi-Omics Insights Multi-Omics Drug Discovery & Development Conference From Data Layers to Therapeutic Breakthroughs Speak,...

Read More

Previous Events

Delegate satisfaction rate
0
Expert Speakers
0
Panel Discussions
0
Focused Driven Day
0

6 Reasons to Attend The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026

6 Reasons to Attend The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026

  1.  Explore the Next Wave of Therapeutic Innovation: Gain insights into emerging obesity drug modalities — from dual and triple agonists to RNA and small-molecule platforms redefining metabolic health. 
  2. Learn from Global R&D and Clinical Leaders: Hear directly from scientists, biotech innovators, and pharma executives driving the next generation of obesity and metabolic disease programs. 
  3. Understand Regulatory and Access Pathways: Navigate EMA and FDA frameworks, HTA alignment, and payer engagement strategies for successful market approval and adoption. 
  4. Accelerate Commercialisation & Partnerships: Identify collaboration and licensing opportunities with global pharma and biotech players shaping the competitive obesity landscape.
  5. Connect Science with Real-World Outcomes: Discover how digital biomarkers, patient registries, and RWE are transforming long-term efficacy and affordability assessments. 
  6. Network Across the Full Obesity Ecosystem: Join a curated audience of R&D innovators, clinicians, investors, and policy experts to forge partnerships and share strategic insights driving the future of obesity therapeutics.

The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026

The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026 unites global R&D leaders, biotech innovators, clinicians, and investors driving the next era of obesity and metabolic disease treatment.

From peptide and RNA therapeutics to small molecules and multi-agonist strategies, this summit bridges cutting-edge science and commercial execution — turning breakthrough research into accessible, effective therapies.

The Next-Wave Obesity Therapeutics & Drug Development Summit Europe 2026

Get in touch for Group Discounted Tickets

Book An Exhibition Stand + 2 Delegate Passes: Book Now For Just: 4,999 €

Discover how you can be a part of this exciting conference and get your expertise in front of your target audience. Packages Include; Exhibition Area, Main Stage Speaking, One-To-One Meetings.

Twoknct Media & Publishing we have exciting offers and news about our upcoming events that we hope you’d like to hear about! We will use your information to predict what you might be interested in. Please remember to check your junk folder for the brochure – and add info@twoknctmedia.com to your safe senders list.

Get in touch for Group Discounted Tickets

To register your team now and benefit from huge group savings, call the conference team on +420 776 164 009 (Prague office) || +44 2038 076 227 (London office)

* We hope you’d like to hear about! We will use your information to predict what you might be interested in.

Venue Details

Hotel SB Plaza Europa

Carrer de les Ciències, 11, 13, 08908 L’Hospitalet de Llobregat, Barcelona, Spain

Sponsors & Partners

Interested?

Still Thinking To Book Your Tickets? Or Know More About Our Speakers.